IR contact details Carla Bretes Director Investor Relations and Business Development e: ir@moonlaketx.com Upcoming events Dec 3 - Dec 5 2024 Citi’s 19th Annual BioPharma Conference 2024 View All Events View All Events + Corporate presentations Corporate presentation View All Presentations View All Presentations + Latest press releases Nov 13 2024 MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Nov 07 2024 MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Sep 09 2024 MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11 View All News View All Press Releases +
Nov 13 2024 MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis
Nov 07 2024 MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update